WEST PHARMACEUTICAL SERVICES (WST) Forecast, Price Target & Analyst Ratings

NYSE:WST • US9553061055

Current stock price

254.8 USD
+2.06 (+0.82%)
At close:
254.8 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for WEST PHARMACEUTICAL SERVICES (WST).

Forecast Snapshot

Consensus Price Target

Price Target
$328.99
+ 29.12% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
$1.69
Revenue Estimate
786.62M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.87%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$328.99
Upside
+ 29.12%
From current price of $254.80 to mean target of $328.99, Based on 23 analyst forecasts
Low
$267.65
Median
$326.40
High
$393.75

Price Target Revisions

1 Month
0.00%
3 Months
-7.08%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for WST. The average price target is 328.99 USD. This implies a price increase of 29.12% is expected in the next year compared to the current price of 254.8.
The average price target has been revised downward by 7.08% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

WST Current Analyst RatingWST Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

WST Historical Analyst RatingsWST Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
80.87%
WST was analyzed by 23 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about WST.
In the previous month the buy percentage consensus was at a similar level.
WST was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-13BarclaysMaintains Equal-Weight -> Equal-Weight
2026-02-03Evercore ISI GroupMaintains Outperform -> Outperform
2025-12-02Morgan StanleyInitiate Equal-Weight
2025-10-29TD CowenInitiate Buy
2025-10-27BarclaysMaintains Equal-Weight -> Equal-Weight
2025-10-24UBSMaintains Buy -> Buy
2025-10-24KeybancMaintains Overweight -> Overweight
2025-10-23Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-02BarclaysMaintains Equal-Weight -> Equal-Weight
2025-09-15Rothschild & CoInitiate Buy
2025-07-25UBSMaintains Buy -> Buy
2025-07-25Evercore ISI GroupMaintains Outperform -> Outperform
2025-06-24BarclaysInitiate Equal-Weight
2025-03-18Evercore ISI GroupInitiate Outperform
2025-02-14KeybancMaintains Overweight -> Overweight
2025-01-08CitigroupInitiate Buy
2024-12-13Wolfe ResearchInitiate Peer Perform
2024-12-13B of A SecuritiesMaintains Buy -> Buy
2024-12-12UBSUpgrade Neutral -> Buy
2024-02-16UBSMaintains Neutral -> Neutral
2024-02-13KeybancMaintains Overweight -> Overweight
2024-02-07JefferiesUpgrade Hold -> Buy
2023-10-27Stephens & Co.Maintains Overweight -> Overweight
2023-08-30KeybancMaintains Overweight -> Overweight
2023-08-21KeybancMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
$1.69
Revenue Estimate
786.62M
Revenue Q2Q
12.70%
EPS Q2Q
16.89%
Number of Analysts
16

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
2.72%
EPS (1 Month)
0.05%
EPS (3 Months)
1.98%

Next Earnings Summary

WST is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is 1.69 USD and the consensus revenue estimate is 786.62M USD.
The next earnings revenue estimate has been revised upward by 2.72% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
WST revenue by date.WST revenue by date.
2.95B
2.18%		2.893B
-1.92%		3.074B
6.25%		3.282B
6.76%		3.484B
6.15%		3.731B
7.09%		4.011B
7.50%		4.065B
1.35%
EBITDA
YoY % growth
WST ebitda by date.WST ebitda by date.
842.4M
-3.78%		744.9M
-11.57%		802.4M
7.72%		881.41M
9.85%		957.97M
8.69%		1.061B
10.76%		1.163B
9.61%		1.161B
-0.17%
EBIT
YoY % growth
WST ebit by date.WST ebit by date.
705.1M
-6.60%		589.5M
-16.39%		631M
7.04%		701.24M
11.13%		777.01M
10.81%		866.79M
11.55%		937.68M
8.18%		957.48M
2.11%
Operating Margin
WST operating margin by date.WST operating margin by date.
23.90%20.38%20.53%21.37%22.30%23.23%23.38%23.55%
EPS
YoY % growth
WST eps by date.WST eps by date.
8.08
-5.72%		6.75
-16.46%		7.29
8.00%		8.10
11.14%		8.99
11.01%		10.14
12.76%		10.87
7.21%		11.47
5.53%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		1.69
16.89%		2.02
9.77%		2.13
8.48%		2.24
9.86%		1.90
12.20%		2.23
10.30%		2.38
11.90%		2.42
7.84%		2.06
8.35%		2.44
9.72%		2.63
10.37%		2.74
13.25%
Revenue
Q2Q % growth		786.62M
12.70%		826.52M
7.83%		825.86M
2.64%		834.88M
3.71%		819.84M
4.22%		867.79M
4.99%		884.49M
7.10%		891.06M
6.73%		854.5M
4.23%		913.74M
5.30%		950.59M
7.47%		960.99M
7.85%
EBITDA
Q2Q % growth		190.45M
14.52%		220.43M
-7.85%		229.68M
-22.80%		237.17M
-31.29%		207.19M
8.79%		234.93M
6.58%		249.06M
8.44%		254.13M
7.15%		221.88M
7.09%		255.55M
8.78%		273.01M
9.62%		284.49M
11.95%
EBIT
Q2Q % growth		146.29M
15.83%		174.31M
10.46%		184.86M
6.79%		193.57M
11.38%		163.91M
12.04%		191.23M
9.71%		204.9M
10.84%		209.8M
8.38%		174.41M
6.41%		208.7M
9.14%		223.5M
9.08%		234.43M
11.74%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

WST Yearly Revenue VS EstimatesWST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
WST Yearly EPS VS EstimatesWST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.63%
EPS Next 5 Year
9.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.43%
Revenue Next 5 Year
5.60%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
19.91%
EBIT Next 5 Year
13.54%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

WEST PHARMACEUTICAL SERVICES / WST Forecast FAQ

What is the price target for WST stock?

23 analysts have analysed WST and the average price target is 328.99 USD. This implies a price increase of 29.12% is expected in the next year compared to the current price of 254.8.

What is the next earnings date for WST stock?

WEST PHARMACEUTICAL SERVICES (WST) will report earnings on 2026-04-23, before the market open.

What are the consensus estimates for WEST PHARMACEUTICAL SERVICES (WST) next earnings?

The consensus EPS estimate for the next earnings of WEST PHARMACEUTICAL SERVICES (WST) is 1.69 USD and the consensus revenue estimate is 786.62M USD.

What is the expected long term growth rate for WST stock?

The expected long term growth rate for WEST PHARMACEUTICAL SERVICES (WST) is 6.43%.